Complete financial analysis of TAAT Global Alternatives Inc. (TOBAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TAAT Global Alternatives Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
- Voestalpine AG (VLPNF) Income Statement Analysis – Financial Results
- Qbic Technology Co., Ltd. (6825.TWO) Income Statement Analysis – Financial Results
- Jason’s Entertainment Co., Ltd. (6583.TWO) Income Statement Analysis – Financial Results
- Nanoveu Limited (NNVUF) Income Statement Analysis – Financial Results
- Hanjin Kal (180640.KS) Income Statement Analysis – Financial Results
TAAT Global Alternatives Inc. (TOBAF)
About TAAT Global Alternatives Inc.
TAAT Global Alternatives Inc., through its subsidiary, TAAT International LLC, manufactures and distributes hemp cigarettes under the Wild Hemp brand name in Canada and the United States. The company was formerly known as TAAT Lifestyle & Wellness Ltd. and changed its name to TAAT Global Alternatives Inc. in April 2021. TAAT Global Alternatives Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 94.62M | 42.54M | 2.56M | 171.19K | 0.00 | 0.00 | 889.77K | 149.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 92.11M | 38.79M | 1.66M | 100.94K | 18.92K | 15.20K | 1.05M | 204.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 2.51M | 3.74M | 905.36K | 70.25K | -18.92K | -15.20K | -163.00K | -55.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 2.65% | 8.80% | 35.36% | 41.04% | 0.00% | 0.00% | -18.32% | -36.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 45.17K | 238.27K | 505.96K | 183.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.36M | 23.86M | 24.56M | 8.08M | 963.00K | 977.11K | 1.34M | 1.50M | 1.26M | 3.20M | 2.70M | 946.74K | 81.45K | 171.63K | 128.64K | 74.52K | 0.00 | 0.00 |
Selling & Marketing | 251.22K | 2.08M | 8.11M | 1.41M | 70.29K | 99.46K | 552.85K | -17.07K | 305.92K | 635.71K | 270.08K | 24.28K | 32.54K | 6.50K | 9.70K | 3.76K | 0.00 | 0.00 |
SG&A | 9.10M | 25.94M | 32.67M | 9.50M | 1.03M | 1.08M | 1.90M | 1.50M | 1.57M | 3.84M | 2.97M | 971.02K | 113.99K | 178.12K | 138.33K | 78.27K | 82.38K | 3.99K |
Other Expenses | 0.00 | 1.86M | 583.46K | 119.49K | -540.63K | 76.65K | 0.00 | 17.07K | 136.25K | 94.20K | 12.73M | 1.33M | 624.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 9.14M | 28.03M | 33.76M | 9.80M | 492.67K | 1.60M | 1.90M | 1.50M | 1.70M | 3.87M | 15.77M | 2.30M | 114.62K | 178.12K | 138.33K | 78.27K | 82.38K | 3.99K |
Cost & Expenses | 101.25M | 66.83M | 35.42M | 9.90M | 492.67K | 1.60M | 2.96M | 1.70M | 1.70M | 3.87M | 15.77M | 2.30M | 114.62K | 178.12K | 138.33K | 78.27K | 82.38K | 3.99K |
Interest Income | 9.46K | 226.47K | 671.00 | 23.68K | 705.00 | 1.09K | 1.21K | 5.26K | 0.00 | 0.00 | 0.00 | 0.00 | 8.97K | 7.75K | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 742.74K | 226.47K | 145.70K | 23.68K | 12.72K | 10.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 303.00 | 800.00 | 423.00 | 203.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.55M | 1.56M | 583.46K | 119.49K | 18.92K | 15.20K | 7.22K | 94.93K | 11.95M | 8.88K | -35.61K | 0.00 | 9.27K | 8.55K | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -7.77M | -22.85M | -32.63M | -11.14M | -1.01M | -1.57M | -1.84M | -1.46M | 10.24M | -3.61M | -15.73M | -2.30M | -105.32K | -170.38K | -138.33K | -78.27K | -82.38K | -3.99K |
EBITDA Ratio | -8.21% | -53.07% | -1,260.20% | -5,613.74% | 0.00% | 0.00% | -206.72% | -3,536.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -6.63M | -24.14M | -32.85M | -9.73M | -454.22K | -1.60M | -2.06M | -1.54M | -1.70M | -3.75M | -15.70M | -2.30M | -114.92K | -178.92K | -138.33K | -78.27K | -82.38K | -3.99K |
Operating Income Ratio | -7.01% | -56.74% | -1,282.99% | -5,683.54% | 0.00% | 0.00% | -231.46% | -1,028.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -4.36M | -3.56M | -6.25M | -1.73M | 536.15K | -35.20K | 77.62K | 3.83M | -11.95M | -405.07K | -156.96K | 101.01K | 8.97K | -348.21K | -423.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | -11.00M | -24.63M | -33.36M | -11.29M | -468.95K | -1.60M | -1.98M | 2.29M | -13.65M | -4.02M | -15.81M | -2.20M | -105.95K | -527.13K | -138.76K | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -11.62% | -57.91% | -1,302.88% | -6,592.37% | 0.00% | 0.00% | -222.74% | 1,534.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 120.97K | 270.68K | 145.70K | -85.27K | 50.47K | 4.88M | -84.84K | -3.83M | 2.00 | 242.72K | 71.90K | 0.00 | 0.00 | -56.21K | 138.76K | 78.48K | 82.64K | 4.02K |
Net Income | -11.12M | -24.90M | -33.51M | -11.20M | -519.41K | -6.48M | -1.98M | 2.29M | -13.65M | -4.02M | -15.81M | -2.20M | -105.95K | -470.92K | -138.76K | -78.48K | -82.64K | -4.02K |
Net Income Ratio | -11.75% | -58.55% | -1,308.57% | -6,542.56% | 0.00% | 0.00% | -222.74% | 1,534.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -1.00 | -2.39 | -3.52 | -1.93 | -0.28 | -6.76 | -3.09 | 8.80 | -51.76 | -16.60 | -77.14 | -20.03 | -1.35 | -8.32 | -9.23 | -5.22 | -6.57 | -0.54 |
EPS Diluted | -1.00 | -2.39 | -3.52 | -1.93 | -0.28 | -6.76 | -3.09 | 8.00 | -51.76 | -16.60 | -77.14 | -20.03 | -1.35 | -8.32 | -9.23 | -5.22 | -6.57 | -0.54 |
Weighted Avg Shares Out | 11.09M | 10.44M | 9.51M | 5.80M | 1.88M | 959.31K | 640.47K | 263.72K | 263.72K | 242.25K | 204.93K | 110.03K | 78.44K | 56.63K | 15.04K | 15.03K | 12.58K | 7.50K |
Weighted Avg Shares Out (Dil) | 11.09M | 10.44M | 9.51M | 5.80M | 1.88M | 959.31K | 640.47K | 286.73K | 263.72K | 242.25K | 204.93K | 110.03K | 78.44K | 56.63K | 15.04K | 15.03K | 12.58K | 7.50K |
TAAT Hits Europe: Over 43,000 Packs of TAAT™ Arrive in London for Distribution in the U.K. and Ireland
TAAT™ Now Sold in Over 1,000 U.S. Stores, More Than 600,000 Packs Sold to Date in U.S.
TAAT™ Exhibiting Among Several “Big Tobacco” Firms at Sold-Out National Convenience Industry Expo NACS Show 2021
REPEAT - New TAAT™ Facilities Now Operational, Tobacco Wholesalers in Germany, Poland, France, and Switzerland Acclaim Reconstituted Beyond Tobacco™ Formulation
New TAAT™ Facilities Now Operational, Tobacco Wholesalers in Germany, Poland, France, and Switzerland Acclaim Reconstituted Beyond Tobacco™ Formulation
TAAT™ to be Sold on Three Continents with Australian Container Order Valued at CAD $536,000
Michigan Tobacco Chain of 147 Stores Places TAAT™ in All Locations Within Weeks of Making Initial Purchase Order
TAAT™ Distributor for U.K. and Ireland Places CAD $1,075,000 Order, Public Health England Issues Confirmation of Registration Authorizing TAAT™ to be Sold in Great Britain
TAAT™ Adds Seven States in Two Months with New Distribution in Alabama, California, Florida, Michigan, and Mississippi
Year in Review: TAAT™ Provides Corporate Update Summarizing its First Year Under Executive Leadership from “Big Tobacco”
Source: https://incomestatements.info
Category: Stock Reports